Litcius/Paper detail

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

Marina Chiara Garassino, Jennifer G. Whisenant, Li‐Ching Huang, Annalisa Trama, Valter Torri, Francesco Agustoni, Javier Baena, Giuseppe Luigi Banna, Rossana Berardi, Anna Bettini, Emilio Bria, Matteo Brighenti, Jacques Cadranel, Alessandro De Toma, Claudio Chini, Alessio Cortellini, Enriqueta Felip, Giovanna Finocchiaro, Pilar Garrido, Carlo Genova, Raffaele Giusti, Vanesa Gregorc, Francesco Grossi, Federica Grosso, Salvatore Intagliata, Nicla La Verde, Stephen V. Liu, Julien Mazières, Edoardo Mercadante, Olivier Michielin, Gabriele Minuti, Denis Moro‐Sibilot, Giulia Pasello, Antonio Passaro, Vieri Scotti, Piergiorgio Solli, Elisa Maria Stroppa, Marcello Tiseo, Giuseppe Viscardi, Luca Voltolini, Yi‐Long Wu, Silvia Zai, Véra Pancaldi, Anne‐Marie C. Dingemans, Jan P. van Meerbeeck, Fabrice Barlési, Heather A. Wakelee, Solange Peters, Leora Horn

2020The Lancet Oncology624 citationsDOIOpen Access PDF

Topics & Concepts

MedicineLung cancerInternal medicineCohortCancer registryPneumoniaOdds ratioPopulationCancerComorbidityStage (stratigraphy)Environmental healthBiologyPaleontologyCOVID-19 and healthcare impactsCOVID-19 Clinical Research StudiesLymphadenopathy Diagnosis and Analysis
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study | Litcius